Respiratory & Anesthesia Devices
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,341
NCT04870333
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
Phase: Phase 2/3
Role: Collaborator
Start: Feb 19, 2021
Completion: Apr 16, 2025
NCT04805333
Phase 1 Dose Escalation of ArtemiCoffee
Phase: Phase 1
Start: Mar 26, 2021
Completion: Feb 4, 2025
NCT05478239
ArtemiCoffee in Patients With Rising PSA
Phase: Phase 2
Start: Aug 11, 2023
Completion: Dec 31, 2026
NCT06286709
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Start: Mar 27, 2024
Completion: Jul 29, 2026
Loading map...